Systematic review on current antiviral therapy in COVID-19 pandemic
There are several attempts to find an effective antiviral drug against the COVID-19. Up to 5-10% of patients may have severe, life-threatening events that urgently require effective drugs. None of the RCTs showed the efficacy of antiviral therapy. In the present pandemic and any future epidemics, all the related authorities should pursue many more RCTs, cohorts, and case series for a prospective outcome in the management and treatment guidelines.
